February 10, 2026

Tracing Metabolic Inflexibility in Fanconi Anemia 

Stable-isotope glucose tracing reveals impaired fuel switching and altered energy use in a rare DNA-repair disorder 

The Analytical Scientist

February 09, 2026

Managing Idiopathic Acute Pancreatitis

Expert panel weighs evidence for genetic testing, cholecystectomy, and ERCP in patients with unexplained acute pancreatitis amid limited guideline direction.

Conexiant

February 09, 2026

When Constipation Signals Something More

Coordinated clinical and public health response supports timely identification and recovery of infant botulism.

Conexiant

February 09, 2026

Short TTP Linked to Infective Endocarditis Risk

While shorter time to blood culture positivity was linked with infective endocarditis, it was not associated with mortality or sepsis in Streptococcus agalactiae bacteremia.

Conexiant

February 09, 2026

Poststroke Spasticity, Seen Too Late

New guidance from the American Heart Association addresses delayed recognition of poststroke spasticity and outlines opportunities to improve timing of rehabilitation care.

Conexiant

February 06, 2026

Autism Diagnosis Timing Varies by Sex

Registry data from Sweden show how autism diagnosis timing differs by sex from childhood through adulthood.

Conexiant

February 06, 2026

When Other People’s Cells Become Our Own

Researchers outline diagnostic hurdles in studying microchimerism and its potential links to health and disease

The Pathologist

February 06, 2026

The Role of AI in Rare Disease Drug Discovery

AI, data-sharing, and gene technologies are peering into the future of rare disease drug development, and overcoming economic, regulatory, and diagnostic challenges for transformative therapies.

The Medicine Maker

February 05, 2026

Oral TYK2 Inhibition in Atopic Dermatitis

Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.

Conexiant